Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

August 16, 2021

Study Completion Date

December 9, 2022

Conditions
Sturge-Weber Syndrome
Interventions
DRUG

Cannabidiol

Initiation of treatment will begin with 5 mg/kg/day given in two divided doses. The dose will be increased by 5 mg/kg/day after seven days and then by 5 mg/kg/day every seven days up to a maximum dose of 20 mg/kg/day given.

Trial Locations (1)

21205

Kennedy Krieger Institute, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Jazz Pharmaceuticals

INDUSTRY

collaborator

Faneca 66 Foundation

OTHER

lead

Anne Comi, MD

OTHER